ArticleTranslational cancer research2023

CD66b as a prognostic and predictive biomarker in patients with non-small cell lung cancer treated with checkpoint blockade immunotherapy.

Swati Jain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.